""

  • , ,
  • : 565


FRESENIUS KABI NORGE (NOR). /. - /.: . 10 20 .
BAXTER HEALTHCARE Corp. (PR) /. 99.9%: . 100 6 .
BAXTER HEALTHCARE Corp. (PR) /. 99.9%: . 250 6 .
(RUS)- /. 10% (1 /10 ): . 10 .
(RUS)- /. 10% (2 /20 ): . 10 .
(RUS)- /. 10% (10 /100 ): . 1 .
(RUS)- /. 10% (20 /200 ): . 1 .
(RUS)- /. 5% (10 /200 ): . 1 .
(RUS)- /. 5% (20 /400 ): . 1 .
(RUS)- /. 5%: . 10 20 , . 50 , 100 , 200 400
(RUS)- /. 10%: . 10 20 , . 50 , 100 , 200 400
(RUS)- /. 20%: . 10 20 , . 50 100
(RUS)- /. 10%: . 50 , 100 200
(RUS)- /. 5%: . 10 20 , . 50 , 100 , 200 400
(RUS)- /. 10%: . 10 20 , . 50 , 100 , 200 400
2 (RUS)- /. 5%: . 10 20 , . 50 , 100 , 200 400
2 (RUS)- /. 10%: . 10 20 , . 50 , 100 , 200 400
2 (RUS)- /. 20%: . 10 20 , . 50 100
(RUS)- /. 10%: . 100 200
- (RUS)- /. 10%: . 100 200
. .. (RUS)- /. 10% (10 /100 ): . 1 .
. .. (RUS)- /. 10% (20 /200 ): . 1 .
(RUS)- /. 10%: . 10 20 , . 50 , 100 , 200 400
(RUS)- /. 10% (10 /100 ): . 1 .
(RUS)- /. 10% (20 /200 ): . 1 .
(RUS)- /. 10% (40 /400 ): . 1 .
(RUS)- /. 10% (5 /50 ): . 1 .
(RUS)- /. 10% (5 /50 ): . 1 .
(RUS)- /. 10% (10 /100 ): . 1 .
(RUS)- /. 10% (20 /200 ): . 1 .
(RUS)- /. 10% (40 /400 ): . 1 .
(RUS)- /. 5% (2.5 /50 ): . 1 .
(RUS)- /. 5% (5 /100 ): . 1 .
(RUS)- /. 5% (10 /200 ): . 1 .
(RUS)- /. 5% (20 /400 ): . 1 .
(RUS)- /. 20% (10 /50 ): . 1 .
(RUS)- /. 20% (20 /100 ): . 1 .
(RUS)- /. 20% (40 /200 ): . 1 .
(RUS)- /. 20% (80 /400 ): . 1 .
. .. (RUS)- /. 10% (10 /100 ): . 1 .
. .. (RUS)- /. 10% (2 /20 ): . 1 .
. .. (RUS)- /. 10% (5 /50 ): . 1 .
. .. (RUS)- /. 10% (20 /200 ): . 1 .
. .. (RUS)- /. 20% (10 /50 ): . 1 .
1 (RUS)- /. 10% (10 /100 ): . 1 .
1 (RUS)- /. 10% (1 /10 ): . 10 .
1 (RUS)- /. 10% (2 /20 ): . 10 .
1 (RUS)- /. 10% (20 /200 ): . 1 .
(RUS)- /. 10% (10 /100 ): . 1 .
(RUS)- /. 10% (5 /50 ): . 1 .
(RUS)- /. 10% (20 /200 ): . 1 .
GREEN CROSS CORP. (SKO)- /. 20%: . 50 100
GREEN CROSS CORP. (SKO)- /. 5%: . 50 100
20%BAXTER (AUT)- // 20%: . 10 20 , . 50 100
DENTSPLY FRANCE (FRA)- /. 72 +21.6 /1.8 : 10 .
FRESENIUS KABI DEUTSCHLAND (DEU)- /. 5%: . 500 10 . 1 6 .
FRESENIUS KABI AUSTRIA (AUT)- /. 5%: . 500 10 . 1 6 .
FRESENIUS KABI DEUTSCHLAND (DEU)- /. 10%: . 500 10 . 1 6 .
FRESENIUS KABI AUSTRIA (AUT)- /. 10%: . 500 10 . 1 6 .
FRESENIUS KABI DEUTSCHLAND (DEU)- /. 15%: . 500 10 . 1 6 .
FRESENIUS KABI AUSTRIA (AUT)- /. 15%: . 500 10 . 1 6 .
FRESENIUS KABI DEUTSCHLAND (DEU)- /. 6%: . 100 10 .
FRESENIUS KABI AUSTRIA (AUT)- /. 6%: . 100 10 .
FRESENIUS KABI DEUTSCHLAND (DEU)- /. 10%: . 100 10 .
FRESENIUS KABI AUSTRIA (AUT)- /. 10%: . 100 10 .
HEMOFARM KONCERN (UGS)- /.: . 500
HEMOFARM KONCERN (UGS)- /.: . 500
®-HEMOFARM KONCERN (SCH)- /. 10%: . 500 1 10 .
®-HEMOFARM KONCERN (SCH)- /. 15%: . 500 1 10 .
®- HEMOFARM KONCERN (SCH)- /. 10%: . 500 1 10 .
KEFRESENIUS KABI DEUTSCHLAND (DEU)- /. 10%: . 500 1 10 .
KEFRESENIUS KABI AUSTRIA (AUT)- /. 10%: . 500 1 10 .
KE FRESENIUS KABI DEUTSCHLAND (DEU)- /.: . 250 10 .
KE FRESENIUS KABI AUSTRIA (AUT)- /.: . 250 10 .
-FRESENIUS KABI DEUTSCHLAND (DEU)- /. 8%: . 500 , 10 .
-FRESENIUS KABI AUSTRIA (AUT)- /. 8%: . 500 , 10 .
PLIVA (HOR)- /. 0.5% (100 /20 ): . 5 .
- (RUS). 300 : 10 20 .
(RUS). // . 4 : . 5 .
(RUS). // . 4 : . 5 .
GEDEON RICHTER (HUN) /. - // 4 : . 25 . .
4% LABORATORY INIBSA (SPN)- /. 40 +5 /1 : 1.8 10 .
4% LABORATORY INIBSA (SPN)- /. 40 +10 /1 : 1.8 10 .
(UKR)- /. 40 +6 /1 : . 1.7 , 1.7 1.8 10 .
(BLR)- /. 5 +1 +2 /1 : . 200 , 400
- (RUS)- /. 5 +1 +2 /1 : . 250 , 500
(RUS)- /. 5 +1 +2 /1 : . 200 400 1 .
(RUS)- /. 5 +1 +2 /1 : . 200 400 1 .
- "" (RUS)- /. 5 +1 +2 /1 : . 200 400 1 .
(RUS)- /. 5 +1 +2 /1 : . 200 , 250 , 400 500 1 .
(RUS)- /. 5 +1 +2 /1 : . 200 400 1 .
(RUS)- /. 5 +1 +2 /1 : . 200 400 1 .
(RUS)- /. 5 +1 +2 /1 : . 250 500 15 .
®LILLY PHARMA Fertigung und Distribution (DEU) /. - // 500 : . 1 .
-- (RUS)- /. 40 +5 /1 : 1.7 1.8 10 .
- - (RUS)- /. 40 +10 /1 : 1.7 1.8 10 .
(RUS)- /. 100 /20 : . 1 .
(RUS)- /. 100 /20 : . 1 .
- (RUS) /. - // . 4 : . 1, 5, 10 25 .
-- (RUS) /. - // . 4 : . 1, 5, 10 25 .
- (RUS) /. - // . 4 : . 1, 5, 10 25 . .
-- (RUS) /. - // . 4 : . 1, 5, 10 25 . .
GRÜNENTHAL (DEU) () 700 : 5 .
FRESENIUS KABI (SWE) /.: . 10 10 .
FRESENIUS KABI DEUTSCHLAND (DEU) /.: . 10 10 .
FRESENIUS KABI (SWE) /.: . 10 10 .
FRESENIUS KABI DEUTSCHLAND (DEU) /.: . 10 10 .
(RUS) /. . / 2 : . 5 .
(RUS) /. . / 50 : .
(RUS) /. . / 100 : .
(BLR) /. . / 2 : . 10 .
- (RUS) /. . / 2 : . 5 .
- (RUS) /. . / 1 : . 5 .
- (RUS) /. . / 5 : . 5 .
- (RUS) /. . / 10 : . 5 .
- (RUS) /. . / 20 : . 5 .
(RUS) /. . / 2 : . 5 .
(RUS) /. . / 5 : . 5 .
(RUS) /. . / 10 : . 5 .
(RUS) /. . / 2 : . 10 .
(RUS) /. . / 5 : . 10 .
(UKR) /. . / 2 : . 10 .
(RUS) /. . / 2 : . 10 .
(RUS) /. . / 5 : . 10 .
(RUS) /. . / 1 : . 10 .
(RUS) /. . / 10 : . 10 .
- (RUS) /. . / 2 : . 5 .
- (RUS) /. . / 1 : . 5 .
- (RUS) /. . / 5 : . 5 .
- (RUS) /. . / 10 : . 5 .
- (RUS) /. . / 20 : . 5 .
(RUS) /. . / 2 : . 10 .
(RUS) /. . / 5 : . 10 .
(RUS) /. . / 5 : . 10 .
(RUS) /. . / 1 : . 10 .
(RUS) /. . / 2 : . 10 .
(RUS) /. . / 3 : . 10 .
(RUS) /. . / 10 : . 10 .
. .. (RUS) /. . / 2 : . 10 .
(RUS) /. . / 1 : . 5 .
(RUS) /. . / 3 : . 5 .
(RUS) /. . / 5 : . 5 .
(RUS) /. . / 10 : . 5 .
(RUS) /. . / 2 : . 5 .
(RUS) /. . / 1 : . 5 .
(RUS) /. . / 5 : . 5 .
(RUS) /. . / 10 : . 5 .
(RUS) /. . / 1.5 : . 5 .
FRESENIUS KABI DEUTSCHLAND (DEU)- /. 6%: . "" 250 500 , 20 30 .; - /. 6%: . 250 500 , 10 .
(LAT) /. - // 1 : . 30 .
-8000 (RUS)- /.: . 200 400 1 .
-8000 (RUS)- /.: . 200 400 1 .
- (RUS)- /.: . 200 1 28 ., . 400 1 15 .
- (RUS)- /.: 250 500 1 .
-- (RUS)- /.: 250 500 1 .
- (RUS)- /.: . 200 400
- (RUS)- /.: . 100 , 200 , 250 , 400 500 1 .
- (RUS)- /.: . 200 400
- (RUS)- /.: 100 , 250 500
- - "" (RUS)- /.: . 200 400
B.BRAUN MELSUNGEN (DEU)- /. 6%: . 250 10 .
B.BRAUN MELSUNGEN (DEU)- /. 10%: . 250 10 .
HEMOFARM KONCERN (UGS)- /.: . 500
-HEMOFARM KONCERN (UGS)- /. 8%: . 500 1 10 .
- (RUS)- /. 6%: . 100 , 200 400
FRESENIUS KABI DEUTSCHLAND (DEU)- /. 60 ( 200/0.5)+72 /1 : . "" 250 20 30 .
HEMOFARM KONCERN (UGS)- /. 5%: . 500
HEMOFARM KONCERN (UGS)- /. 10%: . 500
(RUS)- /. 5%: 200 , 250 , 400 , 500 1
(BLR)- // 40%: . 5 10 .
- "" (RUS)- /. 5%: . 200 1 20 ., 400 1 20 .
- "" (RUS)- /. 10%: . 200 1 20 ., 400 1 20 .
- "" (RUS)- /. 20%: . 200 1 20 ., 400 1 20 .
- (RUS)- /. 5%: 200 , 250 , 400 , 500 1
- (RUS)- /. 10%: 200 , 250 , 400 , 500 1
(RUS)- /. 5%: 200 250 , 400 , 500 1
(RUS)- /. 10%: 200 250 , 400 , 500 1
(RUS)- /. 10%: . 250 15 ., . 500 10 .
(RUS)- /. 5%: . 250 15 ., . 500 10 .
(RUS)- /. 20%: . 250 15 ., . 500 10 .
- (RUS)- /. 5%: . 250 1 15 .
- (RUS)- /. 10%: . 250 1 15 .
- (RUS)- /. 20%: . 250 1 15 .
(RUS)- /. 5%: 100 , 250 , 500 1 .
(RUS)- /. 10%: 100 , 250 , 500 1 .
(RUS)- /. 20%: 100 , 250 , 500 1 .
(RUS)- /. 5%: 250 , 500 1 ., 250 , 500 1 .
(RUS)- // 2 /5 : . 10 .
(RUS)- // 4 /10 : . 10 .
(RUS)- // 2 /5 : . 10 .
(RUS)- // 4 /10 : . 10 .
(RUS)- // 8 /20 : . 10 .
(RUS)- /. 5%: 100 , 250 , 500 1
(RUS)- /. 10%: 100 , 250 , 500 1
(RUS)- /. 20%: 100 , 250 , 500 1
(RUS)- /. 5%: . 200 400
(RUS)- /. 10%: . 200 400
(RUS)- /. 20%: . 200 400
(RUS)- /. 40%: . 200 400
2 (RUS)- /. 5%: . 50 , 100 , 200 400
(RUS)- /. 5%: . 100 , 200 400 20 .
(RUS)- /. 10%: . 100 , 200 400 20 .
(RUS)- /. 5%: . 200 400
(RUS)- /. 10%: 500 14 .
(RUS)- /. 5%: 500 14 .
(RUS)- /. 5%: . 200 400
(RUS)- /. 10%: . 200 400
(RUS)- /. 5%: . 200 400
(RUS)- // 250 /5 : . 10 .
(RUS)- // 500 /10 : . 10 .
(RUS)- // 500 /5 : . 10 .
(RUS)- // 1 /10 : . 10 .
(RUS)- // 1.25 /5 : . 10 .
(RUS)- // 2.5 /10 : . 10 .
(RUS)- // 2 /5 : . 10 .
(RUS)- // 4 /10 : . 10 .
(RUS)- // 40% (2 /5 ): . 10 .
(RUS)- // 40% (2 /5 ): . 10 .
(RUS)- // 40% (4 /10 ): . 10 .
(RUS)- // 40% (4 /10 ): . 10 .
B.BRAUN MELSUNGEN (DEU)- /. 5%: . 250
- (RUS)- /. 20%: . 100 , 200 , 400 1 .
- (RUS)- /. 5%: . 100 , 200 , 400 1 .
- (RUS)- /. 10%: . 100 , 200 , 400 1 .
- (RUS)- /. 40%: . 100 , 200 , 400 1 .
® (RUS)- /. 6 +5 /100 : . 200 400
FRESENIUS KABI DEUTSCHLAND (DEU)- /. 20%: . 500 10 20 .
40 (RUS)- /. 10%: 250 500
40 - "" (RUS)- /. 10%: 200 400
-60- (RUS)- /. 60 /1 : . 100 , 200 400
FRESENIUS KABI AUSTRIA (AUT) /. - /. 20%: . 50 100 , 10 .
ASTRAZENECA (ITA) // 10 /1 : . (200 /20 ) 5 .
ASTRAZENECA UK (GBR) // 10 /1 : . (200 /20 ) 5 .
ASTRAZENECA (ITA) // 10 /1 : (500 /50 ) 1 .
ASTRAZENECA UK (GBR) // 10 /1 : (500 /50 ) 1 .
(BLR)- /. 6 +2 /1 : . 200 , 400
(RUS)- /. 6 +2 /1 : . 200 , 400
(RUS)- /. 6 +2 /1 : . 200 , 400
- "" (RUS)- /. 6 +2 /1 : . 200 , 400
(RUS)- /. 6 +2 /1 : . 200 , 250 , 400 500
(RUS)- /. 6 +2 /1 : . 200 , 400
(RUS)- /. 6 +2 /1 : . 200 , 400
(RUS)- /. 6 +2 /1 : . 200 , 400
(RUS)- // 2% (100 /5 ): . 10 .
- (UKR)- // / 100 /5 : . 10 .
F.Hoffmann-La Roche (CHE)- // / 5 /1 : . 5 10 .
CENEXI (FRA)- // / 5 /1 : . 5 10 .
F.Hoffmann-La Roche (CHE)- // / 15 /3 : . 5, 10 25 .
CENEXI (FRA)- // / 15 /3 : . 5, 10 25 .
F.Hoffmann-La Roche (CHE)., . , 15 : 10, 20, 30 100 .
® 100BERLIN-CHEMIE AG/MENARINI GROUP (DEU)- /.: . 250 500 1 10 ., . 1 6 .
® 40BERLIN-CHEMIE AG/MENARINI GROUP (DEU)- /.: . 100 , 250 500 1 10 .
® 40- (RUS)- /.: . 100 , 250 500 1 10 .
SERUMWERK BERNBURG (DEU)- /. 6%: . 100 , 250 500
SERUMWERK BERNBURG (DEU)- /. 10%: . 100 , 250 500
FRESENIUS KABI DEUTSCHLAND (DEU)- /.: . 250 500 10 20 .
FRESENIUS KABI (SWE) /. 1920 : 2 4 .
FRESENIUS KABI (SWE) /. 2053 : 2 4 .
FRESENIUS KABI (SWE) /. 1540 : 2 4 .
GEDEON RICHTER (HUN)- /. 500 /10 : . 5 .
(RUS)- /.: . 200 400
(RUS)- /.: . 200 400
(RUS)- // / 100 /2 : . 5 .
(RUS)- // / 250 /5 : . 5 .
FRESENIUS KABI DEUTSCHLAND (DEU)., . : 100 .
8000 (RUS)- /.: . 100 , 200 400 1 .
(RUS)- /. 200 , 400 : . 1 .
Human Serum Production and Medicine Manufacturing (HUN)- /. 10% (100 /1 ): . 500
EGIS PHARMACEUTICALS (HUN) /. . 10% (4.8 /1 ): . 38 (650 )
- (RUS) /. . 10%: . 25 38
- (RUS) /. . 10%: . 25 38
(RUS) /. . 5%: 15
(RUS) /. . 100 +500 /1 : . 25
WEIMER PHARMA (DEU)- /. 20 +10 /1 : 1.8 10 50 .
WEIMER PHARMA (DEU)- /. 20 +12.5 /1 : 1.8 10 50 .
UNIQUE PHARMACEUTICAL Laboratories (IND) /. . 20 /1 : 10
J.B. Chemicals & Pharmaceuticals (IND) /. . 20 /1 : 10
FRESENIUS KABI DEUTSCHLAND (DEU) /. 10%: . 100 , 250 500 , 10 .
FRESENIUS KABI DEUTSCHLAND (DEU) /. 20%: . 100 , 250 500 , 10 .
20B.BRAUN MELSUNGEN (DEU) /. 20%: . 100 , 250 , 500
/ 10%B.BRAUN MELSUNGEN (DEU) /. 100 /1 : . 100 , 250 , 500
/ 20%B.BRAUN MELSUNGEN (DEU) /. 200 /1 : . 100 , 250 , 500
NYCOMED AUSTRIA (AUT)- // / 100 /5 : . 5 .
NYCOMED AUSTRIA (AUT)- /. 100 /5 : . 25 .
UNIQUE PHARMACEUTICAL Laboratories (IND)- /. 100 /5 : . 25 .
J.B. Chemicals & Pharmaceuticals (IND)- /. 100 /5 : . 25 .
(RUS)- // / 100 /5 : . 5 .
(RUS) /. . 1% (10 /1 ): 100
L.Molteni & C.Dei Fratelli Alitti Societa Di Esercizio (ITA) /. . 1% (10 /1 ): 100
(RUS) /. . 2.5% (25 /1 ): 15 . .
L.Molteni & C.Dei Fratelli Alitti Societa Di Esercizio (ITA) /. . 2.5% (25 /1 ): 15 . .
ASTRAZENECA MONTS (FRA)- /. 100 /20 : . 5 .
ASTRAZENECA (SWE)- /. 50 +100 /20 : . 5 .
ASTRAZENECA (SWE)- /. 20 /4 : . 5 .
ASTRAZENECA (SWE)- /. 20 /4 : . 5 .
(RUS)- /.: . 400 450
(RUS)- /.: . 400 450
3M ESPE (DEU)- /. 30 /1 : 1.7 50 .
GlaxoSmithKline (ITA)- // . 10 /5 : . 5 .
GlaxoSmithKline (ITA)- // . 20 /10 : . 5 .
LECIVA (CS)- /. 250 : . 1 .
®ASTRAZENECA (SWE)- /. 20 /10 : . 5 .
®ASTRAZENECA (AU)- /. 20 /10 : . 5 .
®ASTRAZENECA (SWE)- /. 75 /10 : . 5 .
®ASTRAZENECA (AU)- /. 75 /10 : . 5 .
®ASTRAZENECA (SWE)- /. 100 /10 : . 5 .
®ASTRAZENECA (AU)- /. 100 /10 : . 5 .
®ASTRAZENECA (SWE)- /. 40 /20 : . 5 .
®ASTRAZENECA (AU)- /. 40 /20 : . 5 .
®ASTRAZENECA (SWE)- /. 150 /20 : . 5 .
®ASTRAZENECA (AU)- /. 150 /20 : . 5 .
®ASTRAZENECA (SWE)- /. 200 /20 : . 5 .
®ASTRAZENECA (AU)- /. 200 /20 : . 5 .
®ASTRAZENECA (SWE)- /. 200 /100 : 5 .
®ASTRAZENECA (AU)- /. 200 /100 : 5 .
®ASTRAZENECA (SWE)- /. 400 /200 : 5 .
®ASTRAZENECA (AU)- /. 400 /200 : 5 .
®ASTRAZENECA (SWE)- /. 50 /10 : . 5 .
®ASTRAZENECA (AU)- /. 50 /10 : . 5 .
®ASTRAZENECA (SWE)- /. 100 /20 : . 5 .
®ASTRAZENECA (AU)- /. 100 /20 : . 5 .
(AM)- /. 5%: . 200 400
(AM)- /. 8.4%: . 200 30 .
(AM)- /. 8.4%: . 20 30 .
- (UKR)- /. 40 /1 : . 200 400
(RUS)◊ /. - / . . 25 :
(RUS)◊ /. - / . . 10 : 5 .
- (RUS)- /. 5%: . 100 , 200 400
(RUS)- // / 1 /5 : . 5 .
(RUS)- /. 20% (1 /5 ): . 10 .
(RUS)- /. 20% (2 /10 ): . 10 .
. .. (RUS)- // 2 /10 : . 10 .
HEMOFARM KONCERN (UGS)- /. 4.5 /500 : . 1 .
(RUS)- /. 0.9%: 200 , 250 , 400 , 500 , 800 1
(RUS)- /. 0.9%: . 200 , 400 1 15 .
(RUS)- /. 0.9%: . 200 , 400 1 15 .
(RUS)- /. 0.9%: . 200 , 400 1 .
(RUS)- /. 0.9%: . 200 1 28 ., . 400 1 15 .
(RUS)- /. 0.9%: . 2 , 5 10 10 .
(RUS)- /. 0.9%: . 200 1 28 ., . 400 1 15 .
(BLR)- /. 0.9%: . 200 1 40 ., . 400 1 24 .
(RUS)- /. 0.9%: . 5 10 10 .
2 (RUS)- /. 0.9%: . 200 1 28 ., . 400 1 15 .
(BLR)- /. 0.9%: . 5 10 10 .
(RUS)- /. 0.9%: 250 , 500 1 1 .
(RUS)- /. 0.9%: . 200 1 24 ., . 400 1 12 .
- (RUS)- /. 0.9%: 250 500 1 .
(RUS)- /. 0.9%: 500 1 .
(RUS)- /. 0.9%: . 250 15 ., . 500 10 .
(RUS)- /. 0.9%: . 200 400
- (RUS)- /. 0.9%: . 250 , 500
(RUS)- /. 0.9%: . 250 , 500
(RUS)- /. 0.9%: . 5 10 10 .
(RUS)- /. 0.9%: 250 , 500
(RUS)- /. 0.9%: . 100 , 200 , 250 400
- (RUS)- /. 0.9%: . 2 , 5 10 10 .
(RUS)- /. 0.9%: . 200 400
(RUS)- /. 0.9%: . 5 10 .
(RUS)- /. 0.9%: . 200 1 28 ., . 400 1 15 .
(RUS)- /. 0.9%: . 200 1 28 ., . 400 1 15 .
(RUS)- /. 0.9%: . 5 10 10 .
(RUS)- /. 0.9%: . 5 10 10 .
(RUS)- /. 0.9%: . 200 1 28 ., . 400 1 15 .
(UKR)- /. 0.9%: . 5 10 10 .
(RUS)- /. 0.9%: . 1 , 5 10 10 .
(RUS)- /. 0.9%: . 100 , 200 400
(RUS)- /. 0.9%: . 1 , 2 , 5 10 10 .
. .. (RUS)- /. 0.9%: . 5 10 10 .
- (RUS)- /. 0.9%: . 1 , 2 , 5 10 10 .
MAPICHEM (CHE)- /. 0.9%: . 5 10 10 .
SISHUI XIERKANG PHARMACEUTICAL (CHI)- /. 0.9%: . 5 10 10 .
- "" (RUS)- /. 0.9%: . 200 , 400 1 .
(RUS)- /. 0.9%: . 200 400
(RUS)- /. 0.9%: . 200 400
(RUS)- /. 0.9%: . 2 , 5 10 10 .
(RUS)- /. 0.9%: 500
(RUS)- /. 0.9%: 250 500
(RUS)- /. 0.9%: . 250 , 1 , 2
(RUS)- /. 0.9%: 250 500 1 .
B.BRAUN MELSUNGEN (DEU)- /. 0.9%: . 100 , 500 1
- (RUS)- /. 0.9%: . 200 , 250 , 400 500 1 .
- (RUS)- /. 0.9%: . 200 1 28 ., . 400 1 15 .
(RUS)- /.: 200 , 250 , 400 500 1, 2, 3 5 .
FRESENIUS KABI DEUTSCHLAND (DEU)- /.: . 250 500 10 . .
FRESENIUS KABI AUSTRIA (AUT)- /.: . 250 500 10 . .
®GlaxoSmithKline (ITA)- // 5 /2.5 : . 5 .
®GlaxoSmithKline (ITA)- // 10 /5 : . 5 .
®GlaxoSmithKline (ITA)- // 20 /10 : . 5 .
(RUS)- /. 0.25%: . 1 , 2 , 5 10 10 .
(RUS)- /. 0.5%: . 1 , 2 , 5 10 10 .
(RUS)- /. 1%: . 1 , 2 , 5 10 10 .
(RUS)- /. 2%: . 1 , 2 , 5 10 10 .
(RUS)- /. 0.5% (25 /5 ): . 10 .
- (RUS)- /. 0.5%: . 1 , 2 5 10 .
- (RUS)- /. 1%: . 1 , 2 5 10 .
- (RUS)- /. 2%: . 1 , 2 5 10 .
(RUS)- /. 0.25%: . 1 , 2 , 5 10 10 .
(RUS)- /. 0.5%: . 1 , 2 , 5 10 10 .
(RUS)- /. 1%: . 1 , 2 , 5 10 10 .
(RUS)- /. 2%: . 1 , 2 , 5 10 10 .
(RUS)- /. 0.25% (500 /200 ): .
(RUS)- /. 0.25% (1 /400 ): .
(RUS)- /. 0.5% (1 /200 ): .
(RUS)- /. 0.5% (2 /400 ): .
(RUS)- /. 0.25% (1 /400 ): .
(RUS)- /. 0.25% (500 /200 ): .
(RUS)- /. 0.5% (1 /200 ): .
(RUS)- /. 0.5% (2 /400 ): .
(RUS)- /. 0.5%: . 2 5 10 .
(RUS)- /. 2%: . 2 5 10 .
(RUS)- /. 0.25%: . 100 , 200 400
(RUS)- /. 0.5%: . 100 , 200 400
(BLR)- /. 0.25%: . 200 400
(BLR)- /. 0.5%: . 200 400
(BLR)- /. 0.5% (10 /2 ): . 10 .
(BLR)- /. 2% (40 /2 ): . 10 .
(RUS)- /. 0.5% (50 /10 ): . 10 .
(RUS)- /. 0.25%: . 200 400
(RUS)- /. 0.5%: . 200 400
(RUS)- /. 0.5%: . 5 10 .
(RUS)- /. 0.25%: . 2 5 10 .
(RUS)- /. 0.5%: . 2 5 10 .
(RUS)- /. 1%: . 2 5 10 .
(RUS)- /. 2%: . 2 5 10 .
(RUS)- /. 5 /1 : . 5 10 10 .
ORGANON (NID) /. - // 4 : . . 10 50 .
FRESENIUS KABI DEUTSCHLAND (DEU) /.: . 50 100 10 .
FRESENIUS KABI AUSTRIA (AUT) /.: . 50 100 10 .
ORGANON (IND)- /. 4 /2 : . 10 .
20TALECRIS BIOTHERAPEUTICS (USA)- /. 20% (10 /50 ): . 1 .
20TALECRIS BIOTHERAPEUTICS (USA)- /. 20% (20 /100 ): . 1 .
(RUS)- /. 6%: . 250 10 .
(RUS)- /. 6 /100 : . 200 1 48 , . 400 1 24 .
- (RUS)- /. 6 /100 : . 200 1 48 , . 400 1 24 .
® (RUS)- /. 6 /100 : . 200 1 28 , . 400 1 15 .
® (RUS)- /. 6 /100 : . 100 , 200 400 1 .
(RUS)- /. 1.5 /100 : . 200 400
DONG KOOK PHARMACEUTICAL (SKO) // 200 /20 : . 5 .
DONG KOOK PHARMACEUTICAL (SKO) // 500 /50 : . 1 .
BHARAT SERUMS & VACCINES (IND) // 1% (200 /20 ): . 1 5 .
BHARAT SERUMS & VACCINES (IND) // 1% (100 /10 ): . 1 5 .
BHARAT SERUMS & VACCINES (IND) // 1% (150 /15 ): . 1 5 .
BHARAT SERUMS & VACCINES (IND) // 1% (500 /50 ): . 1 5 .
FRESENIUS KABI DEUTSCHLAND (DEU) // 10 /1 : . 20 5 .
FRESENIUS KABI AUSTRIA (AUT) // 10 /1 : . 20 5 .
FRESENIUS KABI DEUTSCHLAND (DEU) // 10 /1 : . 50 1 10 .
FRESENIUS KABI AUSTRIA (AUT) // 10 /1 : . 50 1 10 .
FRESENIUS KABI DEUTSCHLAND (DEU) // 10 /1 : . 100 1 10 .
FRESENIUS KABI AUSTRIA (AUT) // 10 /1 : . 100 1 10 .
-B.BRAUN MELSUNGEN (DEU) // 1% (200 /20 ): . 5 .
-B.BRAUN MELSUNGEN (DEU) // 1% (500 /50 ): . 1 .
-B.BRAUN MELSUNGEN (DEU) // 1 /50 : . 1 .
HEMOFARM (RS)- /.: . 500 1 10 .
HEMOFARM (RS)- /.: . 500 1 10 .
® (RUS)- /. 1.5%: . 100 , 200 400 1 .
(RUS)- /. 1.5%: . 400
SCHERING (DEU) // 200 /20 : . 5 .
SCHERING (FIN) // 200 /20 : . 5 .
SCHERING (DEU) // 500 /50 : . 1 .
SCHERING (FIN) // 500 /50 : . 1 .
SCHERING (DEU) // 1 /100 : . 1 .
SCHERING (FIN) // 1 /100 : . 1 .
SCHERING (DEU) // 200 /10 : . 5 .
SCHERING (FIN) // 200 /10 : . 5 .
SCHERING (DEU) // 1 /50 : . 1 .
SCHERING (FIN) // 1 /50 : . 1 .
SCHERING (DEU) // 2 /100 : . 1 .
SCHERING (FIN) // 2 /100 : . 1 .
(RUS)- /. 10 +5 +900 /100 : . 400
(RUS)- /. 10 +5 +900 /100 : . 200 400
(RUS)- /. 10%: . 200 1 28 , . 400 1 15 .
(RUS)- /. 10%: . 200 1 28 , . 400 1 15 .
(BLR)- /. 10%: . 200 1 24 , . 400 1 24 .
(RUS)- /. 10 +5 /100 : . 200 1 28 , . 400 1 15 .
(RUS)- /. 10 +5 /100 : . 200 1 24 , . 400 1 12 .
-40 (RUS)- /. 10%: . 200 , 250 500 1 .
-40 (RUS)- /. 10%: . 200 400 1 .
-40 - (RUS)- /. 10%: . 250 500 1 .
® (RUS)- /. 10%: . 200 400
® (RUS)- /. 10%: . 200 400
130 (RUS)- /. 6% ( 130/0.42): . 250 500
200 (RUS)- /. 6% ( 200/0.5): . 250 500
200 (RUS)- /. 10% ( 200/0.5): . 250 500
® 10%BERLIN-CHEMIE AG/MENARINI GROUP (DEU)- /. 10% ( 200/0.5): . 250 500 1 10 .
® 10%- (RUS)- /. 10% ( 200/0.5): . 250 500 1 10 .
® 6%BERLIN-CHEMIE AG/MENARINI GROUP (DEU)- /. 6% ( 200/0.5): . 250 500 1 10 .
® 6%- (RUS)- /. 6% ( 200/0.5): . 250 500 1 10 .
BALKANPHARMA-TROYAN (BLG)- /.: 500 16 ., . 500 20 .
(RUS)- /.: 500 20 .
(RUS)- /.: 250 32 .
(RUS)- /.: 100 32 .
(RUS)- /.: 200
(RUS)- /.: . 250 500
(RUS)- /.: 250 500
(RUS)- /.: 100 1 .
(RUS)- /.: 250 1 .
(RUS)- /.: 500 1 .
(RUS)- /.: 1 1 .
(RUS)- /.: . 200 1 .
(RUS)- /.: . 400 1 .
- (RUS)- /.: 100 , 250 500
ABBOTT LABORATORIES (GBR) /. 100 : .
ABBOTT LABORATORIES (GBR) /. 250 : .
SEPTODONT (FRA)- /. 40 +5 /1 : 1.8 5 .
SEPTODONT (FRA)- /. 40 +10 /1 : 1.8 5 .
SEPTODONT (FRA)- /. 3%: 1.8 10 .
FRESENIUS KABI DEUTSCHLAND (DEU) /. 20%: . 100 , 250 500 10 .
FRESENIUS KABI AUSTRIA (AUT) /. 20%: . 100 , 250 500 10 .
PHARMACIA & UPJOHN (SWE). /. - /.: . 10 10 .
® 6%BERLIN-CHEMIE AG/MENARINI GROUP (DEU)- /. 6% ( 450/0.7): . 250 500 1 10 .
® 6%- (RUS)- /. 6% ( 450/0.7): . 250 500 1 10 .
B.BRAUN MELSUNGEN (DEU)- /.: . 500 1
(RUS)- // / 100 /5 : . 5 10 .
LEK d.d. (SLO) /. - // 500 : . 25 .
SANDOZ (AUT) /. - // 500 : . 25 .
LEK d.d. (SLO) /. - // 1 : . 25 .
SANDOZ (AUT) /. - // 1 : . 25 .
(RUS) /. - // 500 : . 1, 5, 10 50 .
(RUS) /. - // 1 : . 1, 5 , 10 50 .
-KM (UKR) /. - // 1 : . 40 .
-KM (UKR) /. - // 500 : . 40 .
®GlaxoSmithKline (ITA)- // 25 /2.5 : . 5 .
®GlaxoSmithKline (ITA)- // 50 /5 : . 5 .
(BLR)- /. 5 +1 +4 /1 : . 200 , 400
(RUS)- /. 5 +1 +4 /1 : . 200 , 400
(RUS)- /. 5 +1 +4 /1 : . 200 , 400
(RUS)- /. 5 +1 +4 /1 : . 200 , 400
BERLIN-CHEMIE AG/MENARINI GROUP (DEU)- /. 36.3 +0.37 +1.75 /1 : . 500 10 .
3M ESPE (DEU)- /. 40 +5 /1 : 1.7 50 .
3M ESPE (DEU)- /. 40 +10 /1 : 1.7 50 .
® AVENTIS PHARMA Deutschland (DEU)- /. 68 /1.7 : 100 .
® AVENTIS PHARMA Deutschland (DEU)- /. 80 /2 : . 10 .
® -AVENTIS PHARMA Deutschland (DEU)- /. 68 +10.2 /1.7 : 100 .
® -AVENTIS PHARMA Deutschland (DEU)- /. 80 +12 /2 : . 10 .
® - AVENTIS PHARMA Deutschland (DEU)- /. 68 +20.4 /1.7 : 100 .
® - AVENTIS PHARMA Deutschland (DEU)- /. 80 +24 /2 : . 10 .
KEDRION (ITA)- /. 5%: . 250
KEDRION (ITA)- /. 5%: . 250
KEDRION (ITA)- /. 20%: . 50
KEDRION (ITA)- /. 20%: . 50
KEDRION (ITA)- /. 20%: . 100
KEDRION (ITA)- /. 20%: . 100
KEDRION (ITA)- /. 25%: . 50
KEDRION (ITA)- /. 25%: . 50
ABBOTT LABORATORIES (GBR) /. 100%: . 100 250
RANBAXY LABORATORIES (IND)- // / 1 /1 : . 5 5 .
RANBAXY LABORATORIES (IND)- // / 1 /1 : . 10 5 .
RANBAXY LABORATORIES (IND)- // / 5 /1 : . 10 .
-FRESENIUS KABI DEUTSCHLAND (DEU)- /. 6% ( 200/0.5): . 250 500 10 ., . "" 250 500 10 .
-FRESENIUS KABI DEUTSCHLAND (DEU)- /. 10% ( 200/0.5): . 250 500 10 ., . "" 250 10 20 ., . "" 500 10 15 .
® (RUS)- /.: . 100 , 200 , 400 500
(RUS)- /.: . 200 400
(BLR)- /. 4.75 +1.5 +3.6 /1 : . 200 , 400
(RUS)- /. 4.75 +1.5 +3.6 /1 : . 100 , 200 , 400
(RUS)- /. 4.75 +1.5 +3.6 /1 : . 200 , 400
- "" (RUS)- /. 4.75 +1.5 +3.6 /1 : . 200 , 400
MOLTENI FARMACEUTICI (ITA)- /. 40 +5 /1 : 1.7 10 .
MOLTENI FARMACEUTICI (ITA)- /. 40 +10 /1 : 1.7 10 .
BAXTER HEALTHCARE Corp. (PR)- / 7.5% (75 /1 ): 1.5 , 2 2.5
®ASTRAZENECA (SWE) /. . . 25 +25 /1 : 5 5 . 30 1 .
®RECIP KARLSKOGA (CHE) /. . . 25 +25 /1 : 5 5 . 30 1 .
N.V. ORGANON (NID)- // 50 /5 : . 12 .
N.V. ORGANON (NID)- // 100 /10 : . 10 .
N.V. ORGANON (NID)- /. 250 /25 : . 4 .
ABBOTT (ITA) /. : . 250